VREX Quote, Financials, Valuation and Earnings

Hologic has a net margin of -24.31% compared to Varex Imaging's net margin of 18.08%. Varex Imaging's return on equity of -8.23% beat Hologic's return on equity of 16.05%.

Varex Imaging has a consensus price target of --, signalling upside risk potential of 57%. On the other hand Hologic has an analysts' consensus of $85.85 which suggests that it could grow by 19.82%. Given that Varex Imaging has higher upside potential than Hologic, analysts believe Varex Imaging is more attractive than Hologic.

Varex Imaging has a beta of 0.603, which suggesting that the stock is 39.736% less volatile than S&P 500. In comparison Hologic has a beta of 0.958, suggesting its less volatile than the S&P 500 by 4.165%.

Varex Imaging has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hologic offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Varex Imaging pays -- of its earnings as a dividend. Hologic pays out -- of its earnings as a dividend.

Varex Imaging quarterly revenues are $205.7M, which are smaller than Hologic quarterly revenues of $988M. Varex Imaging's net income of -$50M is lower than Hologic's net income of $178.6M. Notably, Varex Imaging's price-to-earnings ratio is 17.52x while Hologic's PE ratio is 21.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Varex Imaging is 0.72x versus 4.22x for Hologic. Usually stocks with elevated PS ratios are considered overvalued.

Myomo has a net margin of -24.31% compared to Varex Imaging's net margin of -10.5%. Varex Imaging's return on equity of -8.23% beat Myomo's return on equity of -84.04%.

Varex Imaging has a consensus price target of --, signalling upside risk potential of 57%. On the other hand Myomo has an analysts' consensus of $7.04 which suggests that it could grow by 25.27%. Given that Varex Imaging has higher upside potential than Myomo, analysts believe Varex Imaging is more attractive than Myomo.

Varex Imaging has a beta of 0.603, which suggesting that the stock is 39.736% less volatile than S&P 500. In comparison Myomo has a beta of 1.709, suggesting its more volatile than the S&P 500 by 70.858%.

Varex Imaging has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Varex Imaging pays -- of its earnings as a dividend. Myomo pays out -- of its earnings as a dividend.

Varex Imaging quarterly revenues are $205.7M, which are larger than Myomo quarterly revenues of $9.2M. Varex Imaging's net income of -$50M is lower than Myomo's net income of -$966.4K. Notably, Varex Imaging's price-to-earnings ratio is 17.52x while Myomo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Varex Imaging is 0.72x versus 8.94x for Myomo. Usually stocks with elevated PS ratios are considered overvalued.

Nuwellis has a net margin of -24.31% compared to Varex Imaging's net margin of 99.62%. Varex Imaging's return on equity of -8.23% beat Nuwellis's return on equity of -918.02%.

Varex Imaging has a consensus price target of --, signalling upside risk potential of 57%. On the other hand Nuwellis has an analysts' consensus of -- which suggests that it could grow by 1500%. Given that Nuwellis has higher upside potential than Varex Imaging, analysts believe Nuwellis is more attractive than Varex Imaging.

Varex Imaging has a beta of 0.603, which suggesting that the stock is 39.736% less volatile than S&P 500. In comparison Nuwellis has a beta of 0.315, suggesting its less volatile than the S&P 500 by 68.488%.

Varex Imaging has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nuwellis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Varex Imaging pays -- of its earnings as a dividend. Nuwellis pays out -- of its earnings as a dividend.

Varex Imaging quarterly revenues are $205.7M, which are larger than Nuwellis quarterly revenues of $2.4M. Varex Imaging's net income of -$50M is lower than Nuwellis's net income of $2.4M. Notably, Varex Imaging's price-to-earnings ratio is 17.52x while Nuwellis's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Varex Imaging is 0.72x versus 0.06x for Nuwellis. Usually stocks with elevated PS ratios are considered overvalued.

Quanterix has a net margin of -24.31% compared to Varex Imaging's net margin of -27.76%. Varex Imaging's return on equity of -8.23% beat Quanterix's return on equity of -11.45%.

Varex Imaging has a consensus price target of --, signalling upside risk potential of 57%. On the other hand Quanterix has an analysts' consensus of $21.80 which suggests that it could grow by 107.42%. Given that Quanterix has higher upside potential than Varex Imaging, analysts believe Quanterix is more attractive than Varex Imaging.

Varex Imaging has a beta of 0.603, which suggesting that the stock is 39.736% less volatile than S&P 500. In comparison Quanterix has a beta of 1.300, suggesting its more volatile than the S&P 500 by 29.975%.

Varex Imaging has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quanterix offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Varex Imaging pays -- of its earnings as a dividend. Quanterix pays out -- of its earnings as a dividend.

Varex Imaging quarterly revenues are $205.7M, which are larger than Quanterix quarterly revenues of $34.1M. Varex Imaging's net income of -$50M is lower than Quanterix's net income of -$9.5M. Notably, Varex Imaging's price-to-earnings ratio is 17.52x while Quanterix's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Varex Imaging is 0.72x versus 3.12x for Quanterix. Usually stocks with elevated PS ratios are considered overvalued.